✦ LIBER ✦

Pharmacokinetic Analysis (PK) of Immune Globulin Subcutaneous (Human), 10% (IGSC) Administered Intravenously or Subcutaneously in Subjects with Primary Immunodeficiency Diseases (PIDD)

✍ Scribed by Leibl, H.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Schiff, R.I.; Gelmont, D.; Grossman, W.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy Analysis of Immune Globulin Sub

✍ Schiff, R.I.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Leibl, H.; Gelm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

New Immune Globulin Subcutaneous (Human)

✍ Grossman, W.J.; Wasserman, R.L.; Melamed, I.; Stein, M.; Engl, W.; Leibl, H.; Sc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Stein, M.; Wasserman, R.L.; Melamed, I.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Rubinstein, A.; Wasserman, R.L.; Melamed, I.; Stein, M.; McCoy, B.; Engl, W.; Le 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Efficacy, Safety, and Pharmacokinetics o

✍ Richard L. Wasserman; Isaac Melamed; Lisa Kobrynski; Steven D. Strausbaugh; Mark 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 213 KB

Pharmacokinetics and safety of subcutane

✍ R. L. Wasserman; A.-M. Irani; J. Tracy; C. Tsoukas; D. Stark; R. Levy; J. Chen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB